Eric Marie Albert Duranson

Eric Marie Albert Duranson

General Counsel bei INVENTIVA

Vermögen: 47 475 $ am 30.04.2024

50 Jahre
Health Technology
Distribution Services
Consumer Services

Ursprung des Netzwerks ersten Grades von Eric Marie Albert Duranson

EinheitArt der EinheitIndustrie
Public Company Biotechnology 13
10
Subsidiary Biotechnology 10

Unternehmensgrafik - zweiten Grades

Beziehungen zu mehreren Unternehmen

Unternehmensverbindungen über das persönliche Netzwerk von Eric Marie Albert Duranson

UnternehmenSektorVerknüpfte PersonenHauptposition
SANOFI Biotechnology

Wayne Pisano

Olivier Antoine M. Charmeil

Corporate Officer/Principal

Corporate Officer/Principal

Medical Specialties

Heinz Christoph Mäusli

Director/Board Member

Pharmaceuticals: Major

Michel de Wilde

Chief Tech/Sci/R&D Officer

EUROCINE VACCINES AB Pharmaceuticals: Major

Pierre Armand Morgon

Chairman

CEGEDIM Packaged Software

Pierre Armand Morgon

Sales & Marketing

STALLERGENES Pharmaceuticals: Major

Susan Coles

General Counsel

Pharmaceuticals: Major

Susan Coles

Frédéric Cren

Pierre Broqua

Jean Volatier

Nathalie Harroy

General Counsel

Chief Tech/Sci/R&D Officer

Corporate Officer/Principal

Corporate Officer/Principal

Corporate Officer/Principal

Biotechnology

Béatrice de Vos

Chief Tech/Sci/R&D Officer

Chemicals: Specialty

Marie Paule Richard

Didier Hoch

Corporate Officer/Principal

Corporate Officer/Principal

University of British Columbia College/University

Susan Coles

Undergraduate Degree

University of Toronto College/University

Susan Coles

Graduate Degree

INSEAD College/University

Pierre Armand Morgon

Frédéric Cren

Undergraduate Degree

Masters Business Admin

DBV TECHNOLOGIES Pharmaceuticals: Major

Didier Hoch

Director/Board Member

Pharmaceuticals: Other

Didier Hoch

Chairman

THERADIAG Medical Specialties

Pierre Armand Morgon

Chairman

Pharmaceuticals: Major

Michael P. Cooreman

Pierre Broqua

Corporate Officer/Principal

Corporate Officer/Principal

Université Paris Dauphine-PSL College/University

Frédéric Cren

Jean Volatier

Undergraduate Degree

Graduate Degree

ESSEC Business School College/University

Annick Schwebig

Pierre Armand Morgon

Chief Executive Officer

Masters Business Admin

École des Hautes Études Commerciales de Paris College/University

Olivier Antoine M. Charmeil

Eric Michel Dusseux

Undergraduate Degree

Graduate Degree

ESCP Europe Campus Paris College/University

Didier Hoch

Undergraduate Degree

Miscellaneous Commercial Services

Susan Coles

Corporate Officer/Principal

Miscellaneous Commercial Services

Susan Coles

Corporate Officer/Principal

European Vaccine Manufacturers

Didier Hoch

President

Wyeth-Ayerst Research

Béatrice de Vos

Corporate Officer/Principal

DMS IMAGING Biotechnology

Béatrice de Vos

Chief Tech/Sci/R&D Officer

University of Lyon College/University

Didier Hoch

Pierre Armand Morgon

Alice Roudot-Ketelers

Doctorate Degree

Doctorate Degree

Graduate Degree

Miscellaneous Commercial Services

Michel de Wilde

Director/Board Member

Pharmaceuticals: Major

Chris Buyse

Béatrice de Vos

Director/Board Member

Chief Tech/Sci/R&D Officer

Miscellaneous Commercial Services

Didier Hoch

Corporate Officer/Principal

Pharmaceuticals: Major

Frédéric Cren

Pierre Broqua

Nathalie Harroy

Chief Tech/Sci/R&D Officer

Corporate Officer/Principal

Human Resources Officer

University of Antwerp College/University

Chris Buyse

Béatrice de Vos

Graduate Degree

Doctorate Degree

Medical Specialties

Didier Hoch

Director/Board Member

CANSINO BIOLOGICS INC. Biotechnology

Pierre Armand Morgon

Director/Board Member

BioVision

Didier Hoch

Chairman

Myasterix

Didier Hoch

Director/Board Member

Jean Moulin University Law School College/University

Pierre Armand Morgon

Graduate Degree

TME PHARMA N.V. Biotechnology

Susan Coles

Director/Board Member

Pharmaceuticals: Major

Susan Coles

Frédéric Cren

Pierre Broqua

General Counsel

Corporate Officer/Principal

Corporate Officer/Principal

Biotechnology

Susan Coles

Director of Finance/CFO

Biotechnology

Michel de Wilde

Director/Board Member

Miscellaneous Commercial Services

Michel de Wilde

Director/Board Member

VBI VACCINES INC. Biotechnology

Michel de Wilde

Director/Board Member

OSE IMMUNOTHERAPEUTICS Pharmaceuticals: Major

Didier Hoch

Director/Board Member

Aventis Pharma International SAS

Didier Hoch

Corporate Officer/Principal

Underground Charity Foundation

Didier Hoch

Chairman

Statistik

International

Frankreich 24
Vereinigte Staaten 10
Belgien 7
Kanada 5
Deutschland 3

Sektoral

Health Technology 26
Consumer Services 11
Commercial Services 6
Technology Services 2
Finance 2

Operativ

Director/Board Member 102
Corporate Officer/Principal 48
Independent Dir/Board Member 35
Chairman 25
Chief Executive Officer 21
-40 % Zeitlich begrenztes Angebot: Unsere Abonnements führen Sie zu den besten Investitionen von morgen.
PROFITIEREN SIE JETZT